Agilent Technologies Inc. (A)
| Bid | 102.72 |
| Market Cap | 29.28B |
| Revenue (ttm) | 6.53B |
| Net Income (ttm) | 1.26B |
| EPS (ttm) | 4.36 |
| PE Ratio (ttm) | 23.55 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 106.88 |
| Volume | 2,228,076 |
| Avg. Volume (20D) | 2,177,500 |
| Open | 101.15 |
| Previous Close | 99.95 |
| Day's Range | 98.88 - 103.33 |
| 52-Week Range | 96.43 - 155.35 |
| Beta | 1.19 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorpt...
Analyst Forecast
According to 13 analyst ratings, the average rating for A stock is "Hold." The 12-month stock price forecast is $155, which is an increase of 50.94% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · businesswire.com
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA ApprovalSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T ther...
